Journal article
Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation
Cellular signalling, Vol.22(12), pp.1882-1890
2010
DOI: 10.1016/j.cellsig.2010.07.017
PMID: 20688157
Abstract
Asthma is characterised by antigen-mediated mast cell degranulation resulting in secretion of inflammatory mediators. Protein phosphatase 2A (PP2A) is a serine/threonine protein phosphatase composed of a catalytic (PP2A-C) subunit together with a core scaffold (PP2A-A) subunit and a variable, regulatory (PP2A-B) subunit. Previous studies utilising pharmacological inhibition of protein phosphatases have suggested a positive regulatory role for PP2A in mast cell degranulation. In support of this we find that a high okadaic acid concentration (1
μM) inhibits mast cell degranulation. Strikingly, we now show that a low concentration of okadaic acid (0.1
μM) has the opposite effect, resulting in enhanced degranulation. Selective downregulation of the PP2A-Cα subunit by short hairpin RNA also enhanced degranulation of RBL-2H3 mast cells, suggesting that the primary role of PP2A is to negatively regulate degranulation. PP2A-B subunits are responsible for substrate specificity, and carboxymethylation of the PP2A-C subunit alters B subunit binding. We show here that carboxymethylation of PP2A-C is dynamically altered during degranulation and inhibition of methylation decreases degranulation. Moreover downregulation of the PP2A-Bα subunit resulted in decreased MK2 phosphorylation and degranulation, whilst downregulation of the PP2A-B′δ subunit enhanced p38 MAPK phosphorylation and degranulation. Taken together these data show that PP2A is both a positive and negative regulator of mast cell degranulation, and this differential role is regulated by carboxymethylation and specific PP2A-B subunit binding.
Details
- Title: Subtitle
- Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation
- Creators
- Gregory Kranias - School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, AustraliaLauren F Watt - School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, AustraliaHelen Carpenter - School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, AustraliaJeff Holst - Centre for Immunology, St. Vincent's Hospital, University of New South Wales, Sydney, NSW 2010, AustraliaRussell Ludowyke - Centre for Immunology, St. Vincent's Hospital, University of New South Wales, Sydney, NSW 2010, AustraliaStefan Strack - Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USAAlistair T.R Sim - School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, AustraliaNicole M Verrills - School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia
- Resource Type
- Journal article
- Publication Details
- Cellular signalling, Vol.22(12), pp.1882-1890
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.cellsig.2010.07.017
- PMID
- 20688157
- ISSN
- 0898-6568
- eISSN
- 1873-3913
- Language
- English
- Date published
- 2010
- Academic Unit
- Pathology; Iowa Neuroscience Institute; Neuroscience and Pharmacology
- Record Identifier
- 9984040467502771
Metrics
10 Record Views